
Guidance will compel sponsors to consider new enrollment strategies and to be more diverse.
Executive Director of Clinical Science, Regor Pharmaceuticals, Inc.
Guidance will compel sponsors to consider new enrollment strategies and to be more diverse.
Published: June 9th 2022 | Updated: